VisusNano Ltd-preview

Visusnano

VisusNano Ltd

Private

SandwichHealthcare & Life Scienceshttps://www.visusnano.com/

Last Round

Series A

May 9, 2022

Total Funding Raised

$3.99M

Company Overview

VisusNano Ltd is a biotechnology company developing a drug-eluting intraocular lens implant for use in patients undergoing cataract surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

drug-eluting IOLintraocular lensIOLcataract surgerydropless cataract surgeryocular drug deliverydrug delivery platformcontrolled drug releasemedtechimplantable medical deviceophthalmologypre-clinical devicebiodegradable polymerveterinary ophthalmology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VisusNano Ltd Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VisusNano Ltd Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	May 9, 2022
Grant	May 9, 2022
Grant	Sep 1, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Darren Pitt

CSO And Co-Founder, Chief Scientific Officer

Founding Team

Joanna Gould

CEO & Co Founder

Founding Team

Tom Kemp

Chief Technology Officer

Executive Team

VisusNano Ltd Investors

Notable investors and investment history

Investor	Rounds
Innovate UK	Grant
SOSV	Accelerator
Discovery Park Ventures	Grant, Series A
Oxford Innovation Finance	Grant, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 22, 2025
Monthly visitors grew 1900% MoM, reaching 1.4K.
May 9, 2022
$1.7M grant round from Discovery Park Ventures, Innovate UK, and Oxford Innovation Finance.

View all signals

VisusNano Ltd Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VisusNano Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VisusNano Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersSandwich

Employee Range6

Year Founded2016

Last FundingMay 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.